Key result
Hydroxyethyl starch 670/0.75 did not significantly differ from crystalloid in microvascular reactivity or endothelial glycocalyx degradation, despite lower fluid volumes (2800 vs 3925 ml; p<0.001).
Why the study?
Does hydroxyethyl starch improve microvascular reactivity and reduce endothelial glycocalyx degradation compared to crystalloid in patients undergoing off-pump coronary artery bypass graft surgery?
RCT (n=120)
Does hydroxyethyl starch improve microvascular reactivity and reduce endothelial glycocalyx degradation compared to crystalloid in patients undergoing off-pump coronary artery bypass graft surgery?
In patients undergoing off-pump CABG, intra-operative fluid resuscitation with hydroxyethyl starch compared to crystalloid does not significantly affect microvascular reactivity or endothelial glycocalyx degradation, despite reducing total fluid requirements.
Summary The infusion of fluids to patients may affect tissue microcirculation and the endothelial glycocalyx. However, the effects of hydroxyethyl starch and crystalloid on endothelial glycocalyx degradation and microvascular reactivity have not been evaluated in detail. We hypothesised that hydroxyethyl starch may cause less endothelial glycocalyx degradation and better microvascular reactivity than that caused by crystalloid. We randomly allocated 120 patients undergoing off‐pump coronary artery bypass graft surgery to receive up to 20 ml.kg −1 of either hydroxyethyl starch 670/0.75 or crystalloid for intra‐operative fluid resuscitation. Crystalloid was then infused to meet ongoing fluid requirements. During the peri‐operative period, vascular occlusion tests were performed to assess microvascular reactivity, and serum syndecan‐1 was measured as an index of endothelial glycocalyx degradation. The median ( IQR [range]) fluid infused during surgery was significantly less in the hydroxyethyl starch group than the crystalloid group; 2800 (2150–3550 [1400–7300]) vs. 3925 (3100–4725 [1900–6700]) ml, respectively, p < 0.001. Vascular occlusion test parameters, including tissue oxygen saturation, occlusion and recovery slope did not differ significantly between the groups. Peri‐operative changes in syndecan‐1 were not significantly different between the groups. We conclude that, in patients undergoing off‐pump coronary artery bypass graft surgery, compared with crystalloid, the use of hydroxyethyl starch 670/0.75 did not result in significant differences in microvascular reactivity or endothelial glycocalyx degradation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2016) conducted an RCT in off-pump coronary artery bypass graft surgery (n=120). hydroxyethyl starch 670/0.75 vs. crystalloid was evaluated on microvascular reactivity and endothelial glycocalyx degradation. Hydroxyethyl starch 670/0.75 did not significantly differ from crystalloid in microvascular reactivity or endothelial glycocalyx degradation, despite lower fluid volumes (2800 vs 3925 ml; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: